stock

Gilead Sciences, Inc. (GILD)

0
December 2nd, 2020

Share

Stay up to date

Gilead Sciences, Inc. /ˈɡɪliəd/, is an American biopharmaceutical company headquartered in Foster City, California that researches, develops and commercializes drugs. The company focuses primarily on antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C, and influenza, including Harvoni and Sovaldi. Gilead is a member of the NASDAQ Biotechnology Index and the S&P 500.

Financial Statements

Key Info

  • Industry: Biological Product (except Diagnostic) Manufacturing
  • Sector: Manufacturing
  • CEO Name: Daniel O'Day

Key Statistics

  • Stock Price: $61.12
  • Dividend Yield: 4.3%
  • Market Capitalization: $76,615,640,467
  • Shares Outstanding: 1,253,528,149
  • Number of Employees: 11,800
  • Trailing 12-Month EPS: $1
  • Trailing 12-Month DPS: $2.63
  • Payout Ratio: 263.0%

Important Dates

  • Next Earnings Date:
  • Next Ex-Dividend Date: 2020-09-14

Price Trends

  • Current Stock Price: $61.12
  • 52-week high: $82.4
  • 52-week low: $58.15
  • 200-day moving average: $67.47
  • 50-day moving average: $60.25

Performance

  • 1-Month Price Return: 5.1%
  • 3-Month Price Return: -6.2%
  • 6-Month Price Return: -17.1%
  • 1-Year Price Return: -5.6%
  • 2-Year Price Return: -8.5%
  • 5-Year Price Return: -32.7%

Visit the Passiv Stock Directory

Data provided by IEX Cloud

December 2nd, 2020